definiens: means any cash consideration, and subject to Paragraph 4.3(b ), the cash equivalentof all other consideration, received by LICENSEE under each sublicense for the grant of rights under the PATENT RIGHTS, butexcluding : ( a ) any royalty payments on sales of LICENSED PRODUCTS, LICENSED SERVICES and LICENSED METHODS bya sublicensee ( which shall be included as EARNED ROYALTY SUBLICENSE REVENUE ) ; ( b ) any amounts paid by a sublicenseeas bona fide reimbursement for research and development costs at fair market value for materials and full time equivalents;(c ) bona fide loans or any payments in consideration for a grant of equity of the LICENSEE at fair market value ; ( d ) amounts paidfor supplies of product or other tangible materials ; ( e ) amounts paid as reimbursement for expenses directly related to the pursuit, maintenance, and/or defense of PATENT RIGHTS ; ( f ) milestone payments by a sublicensee for a product, service, or method thatis not a LICENSED PRODUCT, LICENSED SERVICE, or LICENSED METHOD ; ( g ) payments by a sublicensee for use of theBIOLOGICAL MATERIALS to identity or optimize products, services, or methods that are not LICENSED PRODUCTS, LICENSED SERVICES, or LICENSED METHODS ; ( h ) withholding taxes and any other amounts by a sublicensee from amountsotherwise payable to LICENSEE under such sublicense agreement other than past due payments ; and ( i ) payments for thesupply of LICENSED PRODUCTS or materials used in the performance of LICENSED SERVICES or LICENSED METHODS